Clinical studies recruiting near Greenville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · Sunbeam Research · R1 Therapeutics · NCT06712654 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Prisma Health Greenville Memorial Hospital · Joseph Broderick, MD · NCT07227246 Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
NA · East Carolina University · East Carolina University · NCT07173205 Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
NA · Prisma Health · Analog Device, Inc. · NCT05650541 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · East Carolina University · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · East Carolina University · National Cancer Institute (NCI) · NCT05099003 The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Phase N/A · Prisma Health - Upstate · Integra LifeSciences Corporation · NCT04494295 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Brody School of Medicine at East Carolina University · Pfizer · NCT06758401 Pounce™ Thrombectomy System Retrospective Registry
Phase N/A · Prisma Health Upstate · SurModics, Inc. · NCT05868161 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · East Carolina University · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Miami Valley Cancer Care and Infusion · NRG Oncology · NCT05624996 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · BI-LO Charities Children's Cancer Center · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · East Carolina University · National Cancer Institute (NCI) · NCT05691478 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Carolina Digestive Diseases and Endoscopy Center · Eli Lilly and Company · NCT07415044 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Brody School of Medicine at East Carolina University · argenx · NCT06544499 Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · Greenville Hospital System University Medical Center (ITOR) · Impact Therapeutics, Inc. · NCT05269316 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Miami Valley Cancer Care and Infusion · PrECOG, LLC. · NCT06538038 A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
Phase 1 · Greenville Hospital System University Medical Center (ITOR) · FBD Biologics Limited · NCT05892718 Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT05877963 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · East Carolina University · Regeneron Pharmaceuticals · NCT06091865 Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · Prisma Health Upstate · Amgen · NCT04221542 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · East Carolina University · Children's Oncology Group · NCT04322318 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Gastroenterology Associates - Patewood · Eli Lilly and Company · NCT06937086 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Prisma Health Cancer Institute · Loxo Oncology, Inc. · NCT05254743 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Miami Valley Cancer Care and Infusion · SWOG Cancer Research Network · NCT06769126 DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac
Phase 2 · Brody School of Medicine at East Carolina University · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617 Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · Research Site · AstraZeneca · NCT06465810 Nectero EAST System Clinical Study
Phase 2/Phase 3 · Prisma Health · Nectero Medical, Inc. · NCT06001918 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · ECU Physicians Nephrology and Hypertension · Biogen · NCT06962800

Look up another city

Look up another condition